Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03757572
Other study ID # Pilonidal QoL
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date December 25, 2018
Est. completion date April 25, 2021

Study information

Verified date May 2021
Source Larissa University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the application of alginate dressings with silver and high-G cellulose and the use of simple gauge dressings in patients submitted to surgical resection of pilonidal cyst. The present trial will focus on the postoperative quality of life during the secondary intention wound healing.


Description:

Read more »
Read more »

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Alginate dressings
The pilonidal cyst will be resected, with the use of a scalpel and then haemostasis will be performed with diathermy. Alginate dressings with silver and high-G cellulose will be applied to the wound. The size of the dressings will be 3cm X 45cm and 1 cm cord will be used for filling the wound cavity. Dressings with perimetric adhesive layer from natural materials, will be also placed. During wound care the wound will be irrigated with normal saline and betadine solution and finally without pressure the trauma will be dried.
Simple gauze dressings
The pilonidal cyst will be resected, with the use of a scalpel and then haemostasis will be performed with diathermy. Simple gauze dressings will be applied to the wound. During wound care the wound will be irrigated with normal saline and betadine solution and finally without pressure the trauma will be dried.

Locations

Country Name City State
Greece University Hospital of Larissa Larissa

Sponsors (2)

Lead Sponsor Collaborator
Larissa University Hospital University of Thessaly

Country where clinical trial is conducted

Greece, 

References & Publications (18)

See more »

Outcome

Type Measure Description Time frame Safety issue
Primary Wound healing time Postoperative required time for wound healing. Measurement unit: days Maximum time frame 50 days postoperatively
Secondary Postoperative return to everyday activities Time required for returning to everyday activities. Measurement unit: days Maximum time frame 50 days postoperatively
Secondary Postoperative pain level Pain level after surgery, quantified with the use of the Visual Analogue Scale (0-10). Better outcome: 0, Worse outcome: 10. There will be no subscales or total scores. 7, 14, 21, 28, 35, 42 and 49 days postoperatively
Secondary Postoperative analgesics consumption Number of analgesic pills consumed per day after surgery. Measurement unit: pills per day 7, 14, 21, 28, 35, 42 and 49 days postoperatively
Secondary Overall satisfaction level Satisfaction level after surgery, quantified with the use of the Visual Analogue Scale (0-10). Better outcome: 10, Worse outcome: 0. There will be no subscales or total scores. 50 days postoperatively
Secondary Cost of the material Overall cost of the dressings applied Maximum time frame 50 days postoperatively
Secondary Wound care visits Number of required visits for postoperative wound care for each patient per week. 7, 14, 21, 28, 35, 42 and 49 days postoperatively
Secondary Trauma secretions Trauma secretions leading to extra dressing care. If such an episode occurs, then it will be defined as=1 'YES' If such an episode does not occur, then it will be defined as=0 'NO' 7, 14, 21, 28, 35, 42 and 49 days postoperatively
Secondary Wound contamination Contamination of the wound trauma. If such an episode occurs, then it will be defined as=1 'YES' If such an episode does not occur, then it will be defined as=0 'NO' Maximum time frame 50 days postoperatively
Secondary Wound erythema Erythema of the wound. If such an episode occurs, then it will be defined as=1 'YES' If such an episode does not occur, then it will be defined as=0 'NO' Maximum time frame 50 days postoperatively
Secondary Wound haematoma Haematoma of the wound. If such an episode occurs, then it will be defined as=1 'YES' If such an episode does not occur, then it will be defined as=0 'NO' Maximum time frame 50 days postoperatively
Secondary Disease recurrence Disease recurrence rate. If such an episode occurs, then it will be defined as=1 'YES' If such an episode does not occur, then it will be defined as=0 'NO' Maximum time frame 1 year postoperatively
Secondary Difference in the quality of life of the patient Difference in the quality of life of the patient based on the Quality of Life with Chronic Wounds Wounds (Qol) Questionnaire. 17 items in total. Each item quantified with the use of a Visual Ordinal Scale (0='not at all' to 4='very much'). Global score computed by averaging all items. In total 3 subscales calculated by averaging the respective items:
Body: Items #1 to #5. Psyche: Items #6 to #10. Everyday life: Items #11 to #16.
7, 14 and 21 days potoperatively
Secondary Medium term quality of life Quality of life of the patient based on the Short Form 36 (SF-36) questionnaire. 36 items in total. The following ordinal scales will be used for the respective items:
1 (Better)-5 (Worse): #1, #2, #20, #22, #34, #36.
1 (Worse)-3 (Better): #3, to #12.
1 (Worse)-2 (Better): #13, to #19.
1 (Better)-6 (Worse): #21, #23, #26, #27, #30.
1 (Worse)-6 (Better): #24, #25, #28, #29, #31.
1 (Worse)-5 (Better): #32, #33, #35. In total 8 subscales calculated by averaging the respective items. Physical functioning: #3 to #12. Role limitations due to physical health: #13 to #16. Role limitations due to emotional problems: #17 to #19. Energy/fatigue: #23, #27, #29, #31. Emotional well-being: #24 to #26, #28, #30. Social functioning: #20, #32. Pain: #21, #22. General health: #1, #33 to #36.
28 days postoperatively
Secondary Treatment satisfaction Patient satisfaction regarding the treatment quantified with the use of a Visual Ordinal Scale (1-5). Better outcome: 5, Worse outcome: 1. There will be no subscales or total scores. 35 days postoperatively
Secondary Treatment acceptance Patient acceptance regarding the re-application of the treatment quantified with the use of a Visual Ordinal Scale (1-5). Better outcome: 5, Worse outcome: 1. There will be no subscales or total scores. 35 days postoperatively
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06406621 - Laser Hair Depilation Darker Skin Pilonidal Disease N/A
Active, not recruiting NCT03772873 - MIPE for Pilonidal Disease